Related Experiment Video
Updated: Apr 18, 2026

12:29
Live Imaging of Antifungal Activity by Human Primary Neutrophils and Monocytes in Response to A. fumigatus
Published on: April 19, 2017
10.8K
Rhinocerebral mucormycosis: a retrospective study
1Department of Otolaryngology and Head and Neck Surgery, Seth GS Medical College and KEM Hospital, Mumbai, Maharashtra India ; Malurthaven 22, st, Herlev, 2730 Copenhagen, Denmark.
Summary
Mucormycosis is a severe fungal infection caused by mucoracea fungi, often fatal. Early diagnosis and treatment are crucial for managing this polymorphic disease, especially rhinocerebral mucormycosis.
Area of Science:
- Mycology
- Infectious Diseases
Background:
- Mucormycosis is an acute, often fatal infection caused by fungi from the Mucoraceae family, primarily Rhizopus, Mucor, and Absidia species.
- These fungi are ubiquitous, found in soil, decaying vegetation, and organic matter.
- Mucormycosis presents as a polymorphic disease with diverse clinical manifestations, including rhinocerebral, pulmonary, cutaneous, cardiac, gastrointestinal, and disseminated forms.
Purpose of the Study:
- To provide an overview of mucormycosis, focusing on its causative agents, epidemiology, and clinical presentations.
- To highlight the significance of rhinocerebral mucormycosis as the most common and often fatal manifestation.
- To emphasize the critical need for early diagnosis and prompt treatment for successful patient management.
Main Methods:
- Review of existing literature on mucormycosis, including etiological agents and clinical classifications.
- Analysis of the epidemiology and risk factors associated with mucormycosis.
- Description of the clinical spectrum and common manifestations, with a focus on rhinocerebral disease.
Main Results:
- Mucormycosis is caused by Mucoraceae fungi, commonly found in the environment.
- Rhinocerebral mucormycosis is the most frequent and fulminant form, often fatal.
- The disease predominantly affects diabetics with ketoacidosis and severely immunocompromised individuals, but can occur in healthy individuals.
Conclusions:
- Mucormycosis is a serious opportunistic infection requiring vigilant diagnostic and therapeutic approaches.
- Prompt recognition and management are essential for improving outcomes in patients with mucormycosis.
- Understanding the diverse clinical presentations and risk factors is key to combating this life-threatening fungal infection.

